Underwood M J, Cooper G, More R, Coumbe A, Toner C, Reynolds P, de Bono D
Bristol Royal Infirmary, United Kingdom.
Cardiovasc Res. 1995 Mar;29(3):422-7.
The aim was to quantify the effect of intraluminally applied tissue-type plasminogen activator (tPA) on the fibrinolytic activity of experimental vein grafts and assess the effect of pretreatment of the vein on early platelet and thrombus formation using histological techniques.
A pig model of bilateral saphenous venin-carotid artery grafts was used. In each animal one side of the neck was grafted using vein distended to 230 mm Hg and pretreated with tPA (1 mg.ml-1) for a period of 15 min before grafting (treated graft). The perfused in situ for 2 h after implantation and before analysis. Changes in local fibrinolytic activity were quantified using fibrin plate techniques and specific chromogenic assays for tPA and urokinase (uPA) in tissue extract (n = 6 animals). Histological assessment was made using light and scanning microscopy (n = 4 animals).
Surgical preparation and distention significantly reduced the fibrinolytic activity of pig saphenous vein in terms of areas of lysis produced on fibrin plates (P < 0.05), tPA activity (P < 0.05), and uPA activity (P < 0.05). Pretreatment of distended vein with tPA before grafting significantly enhanced its fibrinolytic activity after 2 h perfusion compared to control (untreated) grafts, as assessed by areas of lysis on fibrin plates (P < 0.05) and specific tPA activity (P < 0.05). Treated grafts also showed qualitatively less platelet and thrombus formation on histological examination.
Pretreatment of surgically harvested vein by intraluminal application of tPA before grafting enhances its fibrinolytic activity after exposure to 2 h perfusion in vivo. This technique requires further investigation to validate its potential as a means of providing local anticoagulation to veins implanted as arterial grafts thereby reducing the incidence of early graft thrombosis.
本研究旨在量化腔内应用组织型纤溶酶原激活剂(tPA)对实验性静脉移植物纤溶活性的影响,并使用组织学技术评估静脉预处理对早期血小板和血栓形成的影响。
采用双侧大隐静脉 - 颈动脉移植的猪模型。在每只动物中,一侧颈部使用扩张至230 mmHg并在移植前用tPA(1 mg/ml)预处理15分钟的静脉进行移植(处理过的移植物)。植入后原位灌注2小时后进行分析。使用纤维蛋白平板技术以及组织提取物中tPA和尿激酶(uPA)的特异性显色测定法来量化局部纤溶活性(n = 6只动物)。使用光学显微镜和扫描显微镜进行组织学评估(n = 4只动物)。
手术准备和扩张显著降低了猪大隐静脉在纤维蛋白平板上产生的溶解面积方面的纤溶活性(P < 0.05)、tPA活性(P < 0.05)和uPA活性(P < 0.05)。与对照(未处理)移植物相比,移植前用tPA对扩张静脉进行预处理在灌注2小时后显著增强了其纤溶活性,通过纤维蛋白平板上的溶解面积(P < 0.05)和特异性tPA活性(P < 0.05)评估。处理过的移植物在组织学检查中也显示出定性上较少的血小板和血栓形成。
移植前通过腔内应用tPA对手术获取的静脉进行预处理可增强其在体内暴露于2小时灌注后的纤溶活性。该技术需要进一步研究以验证其作为为作为动脉移植物植入的静脉提供局部抗凝从而降低早期移植物血栓形成发生率的手段的潜力。